UPS
51
6
ECL
54
5
CA
19
6
UAL
73
3
ILMN
31
4
STT
48
4
ROP
44
6
A
43
2
NOV
45
2
KR
50
5
URBN
67
3
OXY
42
17
LB
16
9
CME
59
3
PSA
43
6
ZION
49
9
HIG
48
5
SBUX
29
-2
CNP
59
17
O
26
16
UPS
51
6
ECL
54
5
CA
19
6
UAL
73
3
ILMN
31
4
STT
48
4
ROP
44
6
A
43
2
NOV
45
2
KR
50
5
URBN
67
3
OXY
42
17
LB
16
9
CME
59
3
PSA
43
6
ZION
49
9
HIG
48
5
SBUX
29
-2
CNP
59
17
O
26
16
Financhill
Back

bluebird bio Vs. Perspective Therapeutics Industry Stock Comparison

Sell
22

BLUE
bluebird bio

Last Price:
$8.23
Seasonality Move:
-8.48%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
22
bluebird bio (BLUE) is a Sell

Is bluebird bio a Buy, Sell or Hold?

  • The current bluebird bio [BLUE] share price is $8.43. The Score for BLUE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLUE Stock Price Chart

What is bluebird bio's stock price today?

  • The bluebird bio share price today is $8.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

BLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 50.22 Buy
Chaikin Money Flow: -425188 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.24 - 9.66) Buy
Bollinger Bands (100): (7.16 - 14.48) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

BLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.08 Buy
20-day SMA: 8.37 Buy
50-day SMA: 8.58 Sell
200-day SMA: 16.25 Sell
8-day EMA: 8.44 Sell
20-day EMA: 8.34 Buy
50-day EMA: 8.96 Sell
200-day EMA: 18.9 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

bluebird bio Earnings Growth & BLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.31 per share, and an increase next year of $16.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

bluebird bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):